Live feed08:00:00·21mPRReleasevia Quantisnow+2KRAS Inhibitor Market Projected to Reach $7.8 Billion by 2034ByQuantisnow·Wall Street's wire, on your screen.AMGN· Amgen Inc.ONCY· Oncolytics Biotech Inc.RVMD· Revolution Medicines Inc.VSTM· Verastem Inc.LLY· Eli Lilly and CompanyHealth Care
